The big biotech. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. Get a real-time stock price quote for XBI (SPDR S&P BIOTECH ETF). com) BioCryst , Biohaven , Exelixis , and AbbVie make up the remainder of the top 5. View Holdings As of 09/30/2023. 9. While I love Cathie Wood, I just don't see how she can keep this up. In contrast, most. Boron One Announces First Closing of Financing. TipRanks | Stock Market Research, News and Analyst Forecasts. Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. Holdings; Holdings Overlap; Attribution; Fundamental Chart; Scatter Plot; Tech Chart; Stress Test; ESG; Data; More. 97. 01% vs 8. The 10 largest holdings have a combined 17. The S&P Biotechnology Select Industry Index comprises stocks in the S&P Total Market Index that are classified in the GICS Biotechnology sub-industry. 7. $72. 86% upside for this ETF looking through to the average analyst targets of the underlying holdings. 79 as the 52 week high point — that compares with a last trade of $133. 94 per share, with $121. S. Additionally. All 142 XBI Holdings. Looking at the chart above, XBI's low point in its 52 week range is $115. A comparison between ARKG and XBI based on their expense ratio, growth, holdings and how well they match their benchmark performance. The firm has a market cap of $5. The ETF return is roughly 4. 12% in the last one year (as of 03/16/2023). The Direxion Daily S&P Biotech Bull and Bear 3X Shares seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. XBI is suitable for investors seeking to. For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. Both VHT and XBI are ETFs. 81 and $97. $6. 71% of total assets under management. 47 and a beta of 0. 94 per share, with $107. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. . ValueStrategy: Traditional value investing is an investment strategy where stocks are selected that trade for less than their intrinsic values. In addition to holding 155 positions, its top 10 holdings make up just 14. 6738M. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p. Sector Exposure and Top Holdings. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ARGX. The top 10 holdings account for about 11. SPDR S&P Biotech ETF ( NYSEARCA: XBI) is likely in the early to mid stages of a period of underperformance, both versus its larger-cap peers and the broad US stock market. XBI, whose index recently expanded, also owns only a handful of established biotech companies. XBI: Head-To-Head ETF Comparison. 01%). "The top five holdings in XBI, as of Dec. Discover historical prices for XBI stock on Yahoo Finance. 87. ( AMGN) = 9. 79 as the 52 week high point — that compares with a last trade of $126. Price Chart. XBI has a higher expense ratio than XLV (0. Many holdings in XBI are cash positive, and the fund itself is cash positive and earning positive too. Mirati Therapeutics. Its top 10 holdings account for approximately 16. 43. 75. The company has an 88. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. Health Care Select Sector SPDR ETF ETF holdings by MarketWatch. Looking at the chart above, XBI's low point in its 52 week range is $62. For an ETF, this widget displays the top 10 constituents that make up the fund. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style,. 03 per $1,000 of principal). Holdings. Diversification. 87. Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U. 13 and $94. Minafi categorizes both of these funds as large funds. 66 +2. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. Both FBT and XBI are ETFs. The top 10 holdings account for about 14. 46% YTD Daily Total ReturnETF Summary. IBB vs. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. XBI. " The 12-month stock price forecast is $22. Last Price Today's Change Today's Volume : Prospectus. 1% which highlights the scope of the fund and diversification away from company-specific risks. XBI, TGTX, VKTX, NVAX: Large Outflows Detected at ETF. 50 down to $98. Holdings. 67. iShares Biotechnology ETF ETF holdings by MarketWatch. 16bn USD. XBI holdings. Based on its analysis of these factors, SSGA Funds Management, Inc. XBI vs ARKG. 09%: Canada: 1. S&P Select Industry Indices are designed to measure the performance of narrow GICS® sub-industries. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market. All 142 XBI Holdings. 250-391-1110. 67% Top 10 holdings are 16. BBC vs XBI. February 15, 2023 — 10:47 am EST. Performance and Risk. 94 per share, with $116. Sign Up Log In Dashboard LogoutLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. XBI: SPDR S&P Biotech ETF - Fund Holdings. 28% so far this year and in the past one. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. 07. Free ratings, analyses, holdings, benchmarks, quotes, and news. The portfolio maintains a cost advantage over competitors, priced within the cheapest fee quintile among peers. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. View the XBI funds market news. 98 and standard deviation of 40. News & World Report, XBI enjoys volume of 20. Name Symbol % Assets. Reserve your copy today. 33% so far, and is up roughly 4. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks. Quote. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. | Medalist Rating as of Sep 30, 2023 | See State Street Investment Hub. 58. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the XBI: SPDR S&P. 15 billion. 27%: Number of Holdings 29: Price/Book Ratio Price/Book Ratio. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Dividend Yield. The sale of ETFs is subject to an activity assessment fee (from $0. Fund size is a good indication of how many other investors trust this fund. There is no guarantee the funds will achieve their stated investment objectives. The weighted harmonic average of closing market price divided by. Learn everything you need to know about SPDR® S&P Biotech ETF (XBI) and how it ranks compared to other funds. Thu, Nov 9, 1:16 PM ET, Market News Video. 83%: Other: 0. Below is the comparison between BBC and XBI. 06 as the 52 week high point — that compares with a last trade of $102. The index is equal-weighted so that smaller biotech stocks can make it into the portfolio. (“SSGA FM” or the “Adviser”), the investment adviser to the Fund, either may invest the Fund's assets. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. **Close price adjusted for splits and dividend and/or capital gain distributions. US. XBI provides a unique investment focus, as its holdings are largely small and mid-cap biotech firms rather than larger pharmaceutical companies such as Pfizer and Johnson & Johnson . 81% of the total fund's. 00%) Most Recent Dividend 0. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. The top ten holdings in IBB make up 51% of the fund, while the top ten in XBI only account for 12% of the fund. 0. For investors that want to rely on modern portfolio theory rather than assessing biotechnology companies, this is a solid option. Shares Held Weight In Fund. 58 💸. ($423. London. 97. The ETF has a beta of 1. The vast majority of XBI holdings have less than a 1% allocation in the fund. 97% of Total Assets) Name Symbol % Assets; BridgeBio Pharma Inc: BBIO: 2. 20 -4. 7% of assets. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. As of Oct 31 2023. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. XLY News. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where. Holdings; Performance; Risk; Advertisement. The fund's investments total to approximately $6. BlackRock Files for Spot Ethereum ETF. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. View the XBI funds market news. SPDR S&P Biotech ETF (XBI) NYSEArca - Nasdaq Real Time Price. 50. 73% so far this year and is down about -39. $5. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. ETF Report Card. It can be found in the fund’s most recent prospectus. XBI, MDGL, SGEN, NTRA: ETF Outflow Alert. 39. XBI's top 10 holdings account for about 14. 01% vs 0. 39. 94 per share, with $121. 81 and $97. 64 per share, with $174. Further, the fund owns $6. The fund employs an equal-weighted methodology, providing a balanced allocation across small, mid, and large-cap biotech companies. 12% in the last one year (as. 2% Category Average. But that definitely wasn't the case recently. ETFs are subject to market fluctuation and the risks of their underlying investments. 58%). The. Across the 192 current stocks in the fund, all holdings have a weighting between 0. 2013. AU. This major support zone runs from $101. XBI, whose index recently expanded, also owns only a handful of established biotech companies. 15%: Holdings Analysis. View the real-time XBI price chart on Robinhood and decide if you want to buy or sell commission-free. Before you invest in the SPDR ® S&P Biotech ETF (the “Fund”), you may want to review the Fund's prospectus and statement of additional information, which contain more information about the Fund and the risks of investing in the Fund. Looking at the chart above, XBI's low point in its 52 week range is $63. Regeneron has an overall rating of B in our POWR Ratings, where it outranks 79. VHT has a lower expense ratio than XBI (0. Cash and Equivalents. Summary. 26% rating in the component of Value. All 33 ARKK ETF Holdings. Looking at the chart above, XBI's low point in its 52 week range is $62. 08 per unit, that means that analysts see 59. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 23%) Advertisement SPDR S&P Biotech ETF (XBI) NYSEArca - NYSEArca Delayed Price. Below is the comparison between LABU and XBI. Free ratings, analyses, holdings, benchmarks, quotes, and news. 35%. Stocks. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 13%: Number of Holdings 77: Price/Book Ratio Price/Book Ratio. Performance and Risk So far this year, XBI has added roughly 1. •. 79 as the 52 week high point — that compares with a last trade of $116. The fund's investments total to approximately $6. Unlock comprehensive insights, track. With about 151 holdings, it effectively. View and export this data back to 2006. 99% upside for this ETF looking through to the average analyst targets of the underlying holdings. The split for XBI took place on September 11, 2015. 79 in February 2021 and has fallen over (50%) to $76. 13%) Gold 1,980. Major Holdings. And, again, it is in the top 15 holdings by weighting of the biotechnology ETF,. 94 as the 52 week high point — that compares with a last trade of $116. Stocks. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare . MRTX. Below is the comparison between ARKG and XBI. As previously mentioned, the biotech industry is relatively unpredictable, and a company’s success is more binary in this industry than in other sectors of the economy. com) ReturnsXBI's top 10 holdings account for about 10. There is no guarantee the fund will achieve its stated investment objective. 58%: Halozyme Therapeutics Inc:Dollar Tree Inc. 01%). 1% over the past year to close the last trading session at $81. -listed equities in the biotechnology sector. We have highlighted five ETFs from different. Compare fees, performance, dividend yield, holdings, technical indicators, and many other metrics to make a better investment decision. The adjacent table shows a Realtime Rating for several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. As of the latest information, Bullfrog AI Holdings will launch its initial public offering ( IPO) — or the first time a private enterprise distributes its equity shares to retail (public. 19%. The stock holdings of the XBI tends to be re. 38%. 86% so far this year and is down about -32. 2B. View complete XLP exchange traded fund holdings for better informed ETF trading. Currency in USD Follow 2W 10W 9M 72. Top 10 Holdings % Portfolio Weight Market Value USD Sector State Street Instl US Govt MMkt Premier 56. 88%. 4% of the stocks in our database. Company specialized in: Holding Companies. Top 10 Holdings (14. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. Get up to date fund holdings for SPDR S&P Biotech ETF from Zacks Investment Research Learn everything about SPDR S&P Biotech ETF (XBI). Free ratings, analyses, holdings, benchmarks, quotes, and news. XBI. 44 per share, with $92. Below is the comparison between VHT and XBI. 79 as the 52 week high point — that compares with a last trade of $133. 96 on December 31, 2021, to $83 per share at the end of 2022. 11. VICTORIA, BC / ACCESSWIRE / September 27, 2023 / Boron One Holdings Inc. 47 and a beta of 0. XBI holdings. 97. XBI holdings. The top holding in XBI receives just a 1. Learn everything about ROBO Global Healthcare Technology and Innovation ETF (HTEC). In a true biotech bust, where investors can't bear the thought of owning a biotech company ever again, there's little to stop XBI from falling to a near 1 P/B ratio when 80% of its top holdings. 41% so far this year and in the past one year (as of 01/23/2023), respectively. 42 billion worth of. Assets Under Management. Historical Price Data. 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. Performance and Risk. 71%: Number of Holdings 64: Price/Book Ratio Price/Book Ratio. XBI is one of a handful of biotech ETFs available, offering exposure to a corner of the market that can perform well during periods of consolidation and is capable of big jumps in the event of major drug approvals. 264,458,476. S. ETF strategy - SPDR® S&P BIOTECH ETF - Current price data, news, charts and performanceSee the company profile for SPDR S&P Biotech ETF (XBI) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and. The fund tracks the performance of a modified market-cap-weighted index of US biotechnology companies listed on US exchanges. Also includes news, ETF details and other investing information. 7657M. IBB's and XBI's Top Holdings are About to Break Out. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 67. Market Capitalization. ETFs are subject to market fluctuation and the risks of their underlying investments. $5. 45% and is down about -9. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Holdings. XBI has an overall POWR Rating of D, equating to a Sell. The top 10 concentration is much higher than XBI at 38% given it only has 30 holdings compared to XBI's 140+ holdings. According to data from U. 47 million over the past three months. IBB has 8. 81 and $134. 2% Top Ten Holdings. 06 as the 52 week high point — that compares with a last trade of $109. 0. 5x and PE ratio is about 14x. The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). Start Free Trial. SPDR S&P Biotech ETF ETF holdings by MarketWatch. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. $6. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 60 as the 52 week high point — that compares with a last trade of $70. XBI’s Holdings. SPDR S&P BIOTECH ETF. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Its holdings reflect the movement of like 750b worth of companies. 08%. VHT has a lower expense ratio than XBI (0. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. VEEV. View the top holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI). 80% of total assets under management. 75M), Brown Advisory. 2, 2023. This is based on the percent of the fund this stock's assets represent. XBI has traded between $62. Research performance, expense ratio, holdings, and volatility to see if it's the. Again, top 10 holdings. Krane Carbon Cfc (138001) 18. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. With XBI trading at a recent price near $131. 1. Twin City Holdings Ltd from Port Alberni, BC. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. 68%. Top holding Madrigal Pharmaceuticals (NASDAQ:MDGL) makes up just a 3. Vertex Pharmaceuticals (VRTX 0. 84 Billion in assets under management, while XBI has 4. View Top Holdings and Key Holding Information for VanEck Gold Miners ETF (GDX). 88 ; Annual Dividend & Yield 0. 49. Further, the fund owns $6. Oct 10, 2022 01:14PM EDT. The company’s fifty day. XBI's top 10 holdings account for about 11. 73. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. 46% YTD Daily Total Return ETF Summary. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. 81 and $97. Performance. SPDR® S&P Biotech ETF (XBI) Stock Price, Quote, News & Analysis Save 45%! Get early access to our annual Black Friday Sale » XBI SPDR® S&P Biotech ETF. Export data to Excel for your own analysis. The "A+ Metric Rated ETF" field, available to ETF Database Pro members, highlights the best rated ETF in the Emerging Markets Equities category. In XBI, the top five holdings together represent only 9. Holdings. 61%) At close: 04:00PM ESTSeeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: Biotechnology.